Differential responses to Smith D autoantigen by mice with HLA-DR and HLA-DQ transgenes: Dominant responses by HLA-DR3 transgenic mice with diversification of autoantibodies to small nuclear ribonucleoprotein, double-stranded DNA, and nuclear antigens

Journal of Immunology

Volumn 184, Issue 2, 2010, Pages 1085-1091

  Jiang, Chao ^a   Deshmukh, Umesh S ^a   Gaskin, Felicia ^a   Bagavant, Harini ^a   Hanson, Julie ^b   David, Chella S ^b   Fu, Shu Man ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; CELL NUCLEUS ANTIGEN; DOUBLE STRANDED DNA; EPITOPE; HLA DQ ANTIGEN; HLA DQ8 ANTIGEN; HLA DR ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; SMALL NUCLEAR RIBONUCLEOPROTEIN; SMITH D AUTOANTIGEN; UNCLASSIFIED DRUG; DNA; SNRPD1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CELL LYSATE; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENIC MOUSE; WESTERN BLOTTING; ANIMAL; ANTIBODY SPECIFICITY; AUTOIMMUNITY; BIOSYNTHESIS; GENETICS; IMMUNOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIBODY DIVERSITY; ANTIGENS, NUCLEAR; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNITY; DNA; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HLA-DR3 ANTIGEN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, TRANSGENIC; RIBONUCLEOPROTEINS, SMALL NUCLEAR;

EID: 76249117985     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902670     Document Type: Article

References (40)

1. Tan, E. M., A. S. Cohen, J. F. Fries, A. T. Masi, D. J. McShane, N. F. Rothfield, J. G. Schaller, N. Talal, and R. J. Winchester. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25: 1271-1277.
2. Ramos, P. S., J. A. Kelly, C. Gray-McGuire, G. R. Bruner, A. N. Leiran, C. M. Meyer, B. Namjou, K. J. Espe, W. A. Ortmann, M. Reichlin, et al. 2006. Familial aggregation and linkage analysis of autoantibody traits in pedigrees multiplex for systemic lupus erythematosus. Genes Immun. 7: 417-432.
3. Graham, R. R., W. A. Ortmann, C. D. Langefeld, D. Jawaheer, S. A. Selby, P. R. Rodine, E. C. Baechler, K. E. Rohlf, K. B. Shark, K. J. Espe, et al. 2002. Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am. J. Hum. Genet. 71: 543-553.
4. Graham, R. R., W. Ortmann, P. Rodine, K. Espe, C. Langefeld, E. Lange, A. Williams, S. Beck, C. Kyogoku, K. Moser, et al. 2007. Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE. Eur. J. Hum. Genet. 15: 823-830.
5. Reveille, J. D. 2006. The genetic basis of autoantibody production. Autoimmun. Rev. 5: 389-398.
6. Gregersen, J. W., S. Holmes, and L. Fugger. 2004. Humanized animal models for autoimmune diseases. Tissue Antigens 63: 383-394.
7. Mangalam, A. K., G. Rajagopalan, V. Taneja, and C. S. David. 2008. HLA class II transgenic mice mimic human inflammatory diseases. Adv. Immunol. 97: 65-147.
8. Krco, C. J., S. Watanabe, J. Harders, M. M. Griffths, H. Luthra, and C. S. David. 1999. Identification of T cell determinants on human type II collagen recognized by HLA-DQ8 and HLA-DQ6 transgenic mice. J. Immunol. 163: 1661-1665.
9. Congia, M., S. Patel, A. P. Cope, S. De Virgiliis, and G. Sønderstrup. 1998. T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from preproinsulin and proinsulin. Proc. Natl. Acad. Sci. U.S.A. 95: 3833-3838.
10. Mangalam, A. K., M. Khare, C. Krco, M. Rodriguez, and C. David. 2004. Identification of T cell epitopes on human proteolipid protein and induction of experimental autoimmune encephalomyelitis in HLA class II-transgenic mice. Eur. J. Immunol. 34: 280-290.
11. Pennesi, G., M. J. Mattapallil, S. H. Sun, D. Avichezer, P. B. Silver, Z. Karabekian, C. S. David, P. A. Hargrave, J. H. McDowell, W. C. Smith, et al. 2003. A humanized model of experimental autoimmune uveitis in HLA class II transgenic mice. J. Clin. Invest. 111: 1171-1180.
12. Paisansinsup, T., U. S. Deshmukh, V. R. Chowdhary, H. S. Luthra, S. M. Fu, and C. S. David. 2002. HLA class II influences the immune response and antibody diversification to Ro60/Sjögren's syndrome-A: heightened antibody responses and epitope spreading in mice expressing HLA-DR molecules. J. Immunol. 168: 5876-5884.
13. Dudek, N. L., S. Maier, Z. J. Chen, P. A. Mudd, S. I. Mannering, D. C. Jackson, W. Zeng, C. L. Keech, K. Hamlin, Z. J. Pan, et al. 2007. T cell epitopes of the La/SSB autoantigen in humanized transgenic mice expressing the HLA class II haplotype DRB1*0301/DQB1*0201. Arthritis Rheum. 56: 3387-3398.
14. Deshmukh, U. S., C. C. Kannapell, and S. M. Fu. 2002. Immune responses to small nuclear ribonucleoproteins: antigen-dependent distinct B cell epitope spreading patterns in mice immunized with recombinant polypeptides of small nuclear ribonucleoproteins. J. Immunol. 168: 5326-5332.
15. Strauss, G., D. A. Vignali, G. Schönrich, and G. J. Hämmerling. 1994. Negative and positive selection by HLA-DR3(DRw17) molecules in transgenic mice. Immunogenetics 40: 104-108. (Pubitemid 24193959)
16. Bradley, D. S., G. H. Nabozny, S. Cheng, P. Zhou, M. M. Griffiths, H. S. Luthra, and C. S. David. 1997. HLA-DQB1 polymorphism determines incidence, onset, and severity of collagen-induced arthritis in transgenic mice. Implications in human rheumatoid arthritis. J. Clin. Invest. 100: 2227-2234.
17. Nabozny, G. H., J. M. Baisch, S. Cheng, D. Cosgrove, M. M. Griffiths, H. S. Luthra, and C. S. David. 1996. HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J. Exp. Med. 183: 27-37.
18. Pan, S., T. Trejo, J. Hansen, M. Smart, and C. S. David. 1998. HLA-DR4 (DRB1*0401) transgenic mice expressing an altered CD4-binding site: specificity and magnitude of DR4-restricted T cell response. J. Immunol. 161: 2925-2929. (Pubitemid 28425715)
19. Deshmukh, U. S., H. Bagavant, D. Sim, V. Pidiyar, and S. M. Fu. 2007. A SmD peptide induces better antibody responses to other proteins within the small nuclear ribonucleoprotein complex than to SmD protein via intermolecular epitope spreading. J. Immunol. 178: 2565-2571.
20. Bagavant, H., U. S. Deshmukh, H. Wang, T. Ly, and S. M. Fu. 2006. Role for nephritogenic T cells in lupus glomerulonephritis: progression to renal failure is accompanied by T cell activation and expansion in regional lymph nodes. J. Immunol. 177: 8258-8265.
21. Waters, S. T., S. M. Fu, F. Gaskin, U. S. Deshmukh, S. S. Sung, C. C. Kannapell, K. S. Tung, S. B. McEwen, and M. McDuffie. 2001. NZM2328: a new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci. Clin. Immunol. 100: 372-383.
22. Deshmukh, U. S., J. E. Lewis, F. Gaskin, C. C. Kannapell, S. T. Waters, Y. H. Lou, K. S. Tung, and S. M. Fu. 1999. Immune responses to Ro60 and its peptides in mice. I. The nature of the immunogen and endogenous autoantigen determine the specificities of the induced autoantibodies. J. Exp. Med. 189: 531-540.
23. Buckner, J. H., and G. T. Nepom. 2002. Genetics of rheumatoid arthritis: is there a scientific explanation for the human leukocyte antigen association? Curr. Opin. Rheumatol. 14: 254-259.
24. Deshmukh, U. S., H. Bagavant, S. Davis, and S. M. Fu. 2006. Intermolecular epitope spreading within the small nuclear ribonucleoprotein complex is regulated by multiple factors. J. Immunol. 176: S156.
25. Tubb, A., D. U. Ambrocio, and S. M. Fu. 2007. ANA and other serological tests by enzyme-linked immunoabsorbant assays (ELISA) as screening and diagnostic tools for systemic autoimmune disorders by primary care physicians (PCP) prior to making rheumatology referrals: lack of precision and usefulness. Arthritis Rheum. 56: 4294-4295.
26. Tan, E. M., P. H. Schur, R. I. Carr, and H. G. Kunkel. 1966. Deoxyribonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J. Clin. Invest. 45: 1732-1740.
27. Hahn, B. H. 1998. Antibodies to DNA. N. Engl. J. Med. 338: 1359-1368.
28. Munoz, L. E., U. S. Gaipl, and M. Herrmann. 2008. Predictive value of anti-dsDNA autoantibodies: importance of the assay. Autoimmun. Rev. 7: 594-597.
29. Herrmann, M., O. M. Zoller, M. Hagenhofer, R. Voll, and J. R. Kalden. 1996. What triggers anti-dsDNA antibodies? Mol. Biol. Rep. 23: 265-267.
30. Putterman, C., and B. Diamond. 1998. Immunization with a peptide surrogate for double-stranded DNA (dsDNA) induces autoantibody production and renal immunoglobulin deposition. J. Exp. Med. 188: 29-38.
31. Khalil, M., K. Inaba, R. Steinman, J. Ravetch, and B. Diamond. 2001. T cell studies in a peptide-induced model of systemic lupus erythematosus. J. Immunol. 166: 1667-1674. (Pubitemid 32114648)
32. Riemekasten, G., A. Kawald, C. Weiss, A. Meine, J. Marell, R. Klein, B. Hocher, C. Meisel, G. Hausdorf, R. Manz, et al. 2001. Strong acceleration of murine lupus by injection of the SmD1(83-119) peptide. Arthritis Rheum. 44: 2435-2445.
33. Riemekasten, G., D. Langnickel, F. M. Ebling, G. Karpouzas, J. Kalsi, G. Herberth, B. P. Tsao, P. Henklein, S. Langer, G. R. Burmester, et al. 2003. Identification and characterization of SmD183-119-reactive T cells that provide T cell help for pathogenic anti-double-stranded DNA antibodies. Arthritis Rheum. 48: 475-485.
34. Deshmukh, U. S., F. Gaskin, J. E. Lewis, C. C. Kannapell, and S. M. Fu. 2003. Mechanisms of autoantibody diversification to SLE-related autoantigens. Ann. N. Y. Acad. Sci. 987: 91-98.
35. Retter, M. W., P. L. Cohen, R. A. Eisenberg, and S. H. Clarke. 1996. Both Sm and DNA are selecting antigens in the anti-Sm B cell response in autoimmune MRL/lpr mice. J. Immunol. 156: 1296-1306.
36. Reichlin, M., A. Martin, E. Taylor-Albert, K. Tsuzaka, W. Zhang, M. W. Reichlin, E. Koren, F.M. Ebling, B. Tsao, and B.H. Hahn. 1994. Lupus autoantibodies to native DNAcross-react with theAandDSnRNP polypeptides. J. Clin. Invest. 93: 443-449.
37. Koren, E., M. Koscec, M. Wolfson-Reichlin, F. M. Ebling, B. Tsao, B. H. Hahn, and M. Reichlin. 1995. Murine and human antibodies to native DNA that cross-react with the A and D SnRNP polypeptides cause direct injury of cultured kidney cells. J. Immunol. 154: 4857-4864.
38. Gerli, R., and L. Caponi. 2005. Anti-ribosomal P protein antibodies. Autoimmunity 38: 85-92.
39. Deshmukh, U. S., D. Sim, G. Rajagopalan, C. David, F. Gaskin, and S. M. Fu. 2008. HLA-DR3 restricted T cell epitope mimics of a lupus-associated autoantigen can initiate autoimmune responses. Arthritis Rheum. 58: S872.
40. Kim, W. U., A. Sreih, and R. Bucala. 2009. Toll-like receptors in systemic lupus erythematosus; prospects for therapeutic intervention. Autoimmun. Rev. 8: 204-208.